|
90
|
310
|
2qolA |
Human epha3 kinase and juxtamembrane region, y596:y602:s768g triple mutant |
|
90
|
310
|
2qo2A |
Human epha3 kinase and juxtamembrane region, dephosphorylated, apo structure |
|
91
|
311
|
2qonA |
Human epha3 kinase and juxtamembrane region, y596f:y602f:y742a triple mutant |
|
97
|
312
|
2qu6A |
Crystal structure of the vegfr2 kinase domain in complex with a benzoxazole inhibitor |
|
88
|
312
|
2qoqA |
Human epha3 kinase and juxtamembrane region, base, amp-pnp bound structure |
|
21
|
61
|
2qkqA |
Structure of the sam domain of human ephrin type-b receptor 4 |
|
91
|
312
|
2qofA |
Human epha3 kinase and juxtamembrane region, y596f mutant |
|
89
|
310
|
2qooA |
Human epha3 kinase and juxtamembrane region, y596f:y602f:y742f triple mutant |
|
89
|
310
|
2qoiA |
Human epha3 kinase and juxtamembrane region, y596f:y602f double mutant |
|
93
|
298
|
2pvyA |
Crystal structure of fgf receptor 2 (fgfr2) kinase domain harboring the pathogenic k659n mutation responsible for an unclassified craniosynostosis syndrome. |
|
93
|
294
|
2qocA |
Human epha3 kinase domain, phosphorylated, amp-pnp bound structure |
|
89
|
310
|
2qodA |
Human epha3 kinase and juxtamembrane region, y602f mutant |
|
30
|
176
|
2qbxA |
Ephb2/snew antagonistic peptide complex |
|
90
|
310
|
2qo7A |
Human epha3 kinase and juxtamembrane region, dephosphorylated, amp-pnp bound |
|
88
|
310
|
2qokA |
Human epha3 kinase and juxtamembrane region, y596f:y602f:s768a triple mutant |
|
90
|
299
|
2pvfA |
Crystal structure of tyrosine phosphorylated activated fgf receptor 2 (fgfr2) kinase domain in complex with atp analog and substrate peptide |
|
91
|
297
|
2qo9A |
Human epha3 kinase and juxtamembrane region, phosphorylated, amp-pnp bound |
|
93
|
298
|
2pwlA |
Crystal structure of fgf receptor 2 (fgfr2) kinase domain harboring the pathogenic n549h mutation responsible for crouzon syndrome. |
|
94
|
298
|
2qobA |
Human epha3 kinase domain, base structure |
|
89
|
298
|
2psqA |
Crystal structure of unphosphorylated unactivated wild type fgf receptor 2 (fgfr2) kinase domain |
|
86
|
298
|
2pzrA |
Crystal structure of fgf receptor 2 (fgfr2) kinase domain harboring the pathogenic k641r mutation responsible for pfeiffer syndrome |
|
92
|
299
|
2pz5A |
Crystal structure of fgf receptor 2 (fgfr2) kinase domain harboring the pathogenic n549t mutation responsible for pfeiffer syndrome |
|
0
|
12
|
2pleB |
Nuclear magnetic resonance structure of an sh2 domain of phospholipase c-gamma1 complexed with a high affinity binding peptide |
|
92
|
299
|
2pzpA |
Crystal structure of fgf receptor 2 (fgfr2) kinase domain harboring the pathogenic k526e mutation responsible for crouzon syndrome |
|
99
|
311
|
2p2hA |
Crystal structure of the vegfr2 kinase domain in complex with a pyridinyl-triazine inhibitor |
|
90
|
298
|
2q0bA |
Crystal structure of fgf receptor 2 (fgfr2) kinase domain harboring the pathogenic e565a mutation responsible for pfeiffer syndrome |
|
93
|
299
|
2py3A |
Crystal structure of fgf receptor 2 (fgfr2) kinase domain harboring the pathogenic e565g mutation responsible for pfeiffer syndrome |
|
94
|
312
|
2p2iA |
Crystal structure of the vegfr2 kinase domain in complex with a nicotinamide inhibitor |
|
74
|
280
|
2p4iA |
Evolution of a highly selective and potent 2-(pyridin-2-yl)-1,3,5-triazine tie-2 kinase inhibitor |
|
75
|
287
|
2p0cA |
Catalytic domain of the proto-oncogene tyrosine-protein kinase mer |
|
0
|
12
|
2pldB |
Nuclear magnetic resonance structure of an sh2 domain of phospholipase c-gamma1 complexed with a high affinity binding peptide |
|
84
|
282
|
2oo8X |
Synthesis, structural analysis, and sar studies of triazine derivatives as potent, selective tie-2 inhibitors |
|
93
|
303
|
2oj9A |
Structure of igf-1r kinase domain complexed with a benzimidazole inhibitor |
|
86
|
317
|
2ogvA |
Crystal structure of the autoinhibited human c-fms kinase domain |
|
95
|
305
|
2oh4A |
Crystal structure of vegfr2 with a benzimidazole-urea inhibitor |
|
80
|
280
|
2oscA |
Synthesis, structural analysis, and sar studies of triazine derivatives as potent, selective tie-2 inhibitors |
|
21
|
58
|
2n2aA |
Spatial structure of her2/erbb2 dimeric transmembrane domain in the presence of cytoplasmic juxtamembrane domains |
|
13
|
44
|
2lcxA |
Spatial structure of the erbb4 dimeric tm domain |
|
10
|
39
|
2n90A |
Trka transmembrane domain nmr structure in dpc micelles |
|
10
|
43
|
2lzlA |
Fgfr3tm |
|
15
|
54
|
2n5sA |
Spatial structure of egfr transmembrane and juxtamembrane domains in dpc micelles |
|
14
|
183
|
2lw8A |
Nmr solution structure of eph receptor |
|
50
|
275
|
2o26U |
Structure of a class iii rtk signaling assembly |
|
15
|
57
|
2mfrA |
Solution structure of the transmembrane domain of the insulin receptor in micelles |
|
12
|
44
|
2m0bA |
Homodimeric transmembrane domain of the human receptor tyrosine kinase erbb1 (egfr, her1) in micelles |
|
12
|
39
|
2l6wA |
Pdgfr beta-tm |
|
13
|
44
|
2l2tA |
Solution nmr structure of the erbb4 dimeric membrane domain |
|
20
|
65
|
2ksoA |
Epha2:ship2 sam:sam complex |
|
27
|
153
|
2kuqA |
Solution structure of the chimera of the ptb domain of snt-2 and 19-residue peptide (aa 1571-1589) of halk |
|
11
|
44
|
2ks1B |
Heterodimeric association of transmembrane domains of erbb1 and erbb2 receptors enabling kinase activation |
